NEUROLOGICAL SYSTEM
1. The client is taking carbamazepine (Tegretol) for treatment of epilepsy. The nurse reinforces the importance of coming to the laboratory weekly for follow-up monitoring of which of the following
...
NEUROLOGICAL SYSTEM
1. The client is taking carbamazepine (Tegretol) for treatment of epilepsy. The nurse reinforces the importance of coming to the laboratory weekly for follow-up monitoring of which of the following?
1-Serum glucose level. 2-Agranulocytosis
3-Alanine aminotransferase (ALT) 4-Proteinuria
2. A 62 years old female client newly diagnosed with idiopathic seizures is taking carbamazepine (Tegretol). The nurse provides which of the following instructions to the client:
1- Initially, the drug may cause drowsiness.
2- Do not abruptly discontinue ingesting the drug. 3-Schedule a bone density exam periodically.
4-Avoid ingesting this drug with over the counter drugs without taking the prescriber.
3. A nurse is caring for a child receiving carbamazepine (Tegretol), who has a carbamazepine level drawn. Which of the following results indicates therapeutic level?
1-1 mcg/ml
2- 3mcg/ml
3- 6mcg/ml
4- 15 mcg/ml
4. A possible adverse reaction to Sodium Valproate (Depakote) is:
1-Hypoglycemia 2-Leukocytosis
3-3-Hyperlipidemia 4-Thrombocytopenia
5. A client has an order to receive valproic acid (Depakene) once daily. To maximize the client’s safety, the nurse schedules administration of the medication:
1- With lunch.
2- With breakfast.
3- Before breakfast.
4- At bedtime with a snack.
6. The nurse concludes that the client has adequate knowledge of the side effects of phenobarbital sodium (Luminal) when the client states, “I should call the doctor if I develop:
1-Respiratory problems or persistent fatigue”. 2-Dizziness when I stand up quickly”.
3- Early morning drowsiness only in the first weeks”.
4- Decreased tolerance to common foods or constipation.
...................................................................................continued.......................................................................................
[Show More]